Mylan Pharmaceuticals ULC, the Canadian unit of Mylan Inc. ( MYL) said Thursday that it received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg.
According to IMS Health, sales of Rosuvastatin Calcium Tablets in Canada was about C$742 million for the year ended Dec. 31, 2011.
Mylan-Rosuvastatin is the generic version of Astra Zeneca Plc's (AZN) Crestor Tablets. The drug is used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.